-
Founded in:
2004-12-15 -
Country:
China -
Address:
No. 53, Zhangju Road, Luancheng District, Shijiazhuang City, Hebei Province -
Tax NO.:
91130100769813764U -
Registered Funds:
100 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| COPTIDISRHIZOMA |
|
0 | ||
| Phellodendri Chinensis Cortex |
|
0 | ||
| Chrysophanic acid |
|
481-74-3 | 0 | |
| LACCA |
|
0 | ||
| Riligustilide |
|
89354-45-0 | 0 | |
| Angelicae Dahuricae Radix |
|
0 | ||
| Asari Radix et Rhizoma |
|
0 | ||
| CARTHAMI FLOS |
|
0 | ||
| Garden Burnet Root |
|
0 | ||
| Elm bark extract |
|
0 | ||
| Sophora japonica bark |
|
0 | ||
| Borneol |
|
507-70-0 | 1 | |
| Ethanol |
|
64-17-5 | 90 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Furazolidone |
|
67-45-8 | 12 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Erythromycin Estolate |
|
3521-62-8 | 24 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Yanhusuo (made with vinegar) |
|
0 | ||
| Alum (calcined) |
|
0 | ||
| Sea octopus (shelled) |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole [ring-3H] C10H11N3O3S |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
0 | ||
| [[(1-PHENYL-1H-TETRAZOL-5-YL)METHYL]THIO]ACETIC ACID |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
746606-46-2 | 0 | |
| Benomyl-d4 (benzimidazole-4,5,6,7-d4) |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
1398065-98-9 | 0 |